Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Chemicals

Covestro Shares Surge as ADNOC Acquisition Nears Approval

Andreas Sommer by Andreas Sommer
October 1, 2025
in Chemicals, DAX, Mergers & Acquisitions
0
Covestro Stock
0
SHARES
107
VIEWS
Share on FacebookShare on Twitter

Significant progress is being made in the multi-billion euro acquisition of German chemical producer Covestro by Abu Dhabi’s state-owned energy giant ADNOC. After months of regulatory challenges, participants are expressing genuine confidence for the first time, triggering enthusiastic market response.

Market Responds with Strong Gains

Covestro’s stock delivered its strongest trading performance in over a year, soaring 5.5 percent following growing optimism about the deal’s prospects. Market analyst Thomas Schulte-Vorwick of Metzler characterized the developments as “incrementally positive news” that improves the likelihood of successful deal completion.

The acquisition premium of €62 per share continues to offer Covestro investors an attractive premium compared to the current trading level of approximately €60. For ADNOC, securing Covestro would provide access to the company’s leading expertise in polyurethanes and polycarbonates—essential materials for automotive, construction, and electronics industries.

Regulatory Hurdles Addressed Through Concessions

The European Commission has been conducting intensive scrutiny of the €14.7 billion transaction under its Foreign Subsidies Regulation framework. Regulators have expressed concerns about potential unfair competition advantages stemming from state-backed financial support from the United Arab Emirates.

Should investors sell immediately? Or is it worth buying Covestro?

In response to these concerns, ADNOC is preparing to submit a package of concessions to EU regulators as early as next week. Key elements include:
* Conversion of a €1.2 billion capital increase into a shareholder loan at market terms
* Commitment to maintain Covestro’s technology and intellectual property within Europe
* Assurance addressing fears about potential technology transfer to the Gulf region

ADNOC Executive Expresses Confidence

Klaus Froehlich, Group Chief Investment Officer at ADNOC, struck an optimistic tone in comments to Handelsblatt, emphasizing his company’s long-term investment approach. “We are strategic, long-term investors. That’s why I’m fundamentally quite optimistic,” he stated.

Froehlich simultaneously cautioned against excessive demands from European regulators, noting the necessity for “a balance between legitimate requirements and excessive demands.” These comments arrive at a crucial juncture in the negotiation process, with regulatory approval representing the final significant obstacle to transaction completion.

Ad

Covestro Stock: Buy or Sell?! New Covestro Analysis from March 25 delivers the answer:

The latest Covestro figures speak for themselves: Urgent action needed for Covestro investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Covestro: Buy or sell? Read more here...

Tags: Covestro
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Unitedhealth Stock
Analysis

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026
CyberArk Software Stock
Bonds

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

March 24, 2026
Galantas Gold Stock
Commodities

Galantas Gold Charts a New Course Through Strategic Diversification

March 24, 2026
Next Post
Valneva Stock

Valneva Shares Surge on Breakthrough Vaccine Data

Deutsche Bank Stock

Significant Stakeholder Moves at Deutsche Bank Spark Market Interest

Super Micro Computer Stock

Super Micro Computer Stock: A Market at a Crossroads

Recommended

Banner Stock

All Eyes on Fed as Banner Corporation Awaits Rate Decision

6 months ago
Dynatrace Holdings LLC Stock

Dynatrace Holdings LLC Stock: Strong Q1 Performance Beats Expectations

8 months ago
MP Materials Stock

MP Materials: Record Production Amid Financial Headwinds

4 months ago
Omv Stock

OMV Faces Critical Juncture as Qatar Threatens European Gas Supplies

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Trending

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

by Jackson Burston
March 25, 2026
0

Fair Isaac Corporation, the company behind the ubiquitous FICO credit score, is facing a dual-pronged assault that...

Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem
  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com